Highlights
- 1
- 2
Publications
44 publications
Funding
8 grantsView NIH portfolio on RePORTER ↗
Active
1 grant- PIR01CA244413-05To study the EMT contributions in tumor metastasis and chemoresistance by using lineage tracing modelsNational Cancer Institute · 2020–2026
Completed grants (7)
- PIAddgene 693625Addgene 693625Addgene, Inc. · 2022–2023
- PIR01CA205418-05Targeting the Epithelial to Mesenchymal Transition-Related Chemoresistance in Breast CancerNational Cancer Institute · 2016–2021
- KPU01CA188388-04Modeling Tumor-Stroma Crosstalk in Lung Cancer to Identify Targets for TherapyNational Cancer Institute · 2015–2020 · via Methodist Hospital Research Institute
- KPU54CA149196-05 EWCenter for Systematic Modeling of Cancer DevelopmentNational Cancer Institute · 2014–2016 · via Methodist Hospital Research Institute
- KPR01CA135417-01A2Molecular Mechanisms of Tumor-Initiated Premetastatic Niche Formation in Lung StromaNational Cancer Institute · 2010–2015
- KPU54CA143876-05 EWCenter on the Microenvironment and MetastasisNational Cancer Institute · 2009–2015 · via Cornell University - Ithaca
- KPRC1CA146065-02EWOMicrofluidic Tumor Models to Analyze the Role of Physiochemical Cues in the Agniogenic SwitchNational Cancer Institute · 2009–2011 · via Cornell University - Ithaca
News mentions
1 mentionView all WCM news ↗
- Scientists Find a New Way to Reverse Immune Suppression in TumorsSeptember 20, 2021
Malignant tumors can enhance their ability to survive and spread by suppressing antitumor immune cells in their vicinity, but a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian has uncovered a new way to counter this immunosuppressive effect.